SARS-CoV-2 in health and care staff in Norway, 2020

Tidsskr Nor Laegeforen. 2021 Feb 9;141(3). doi: 10.4045/tidsskr.20.1048. Print 2021 Feb 23.
[Article in English, Norwegian]

Abstract

Background: The COVID-19 pandemic is placing considerable pressure on health services around the world. In Norway, the incidence rate among the working-age population (20-69 years) for the whole of 2020 was 1.11 %. In this study, we describe diagnosed infection among staff in the health service, based on register data.

Material and method: From the emergency preparedness register, Beredt C19, we identified 382 332 persons employed in selected occupational groups in the health service in week 9 of 2020, and investigated incidence and testing activity for diagnosed SARS-CoV-2 according to occupation, age, sex, country of birth, place of residence and place of work, for the whole of 2020.

Results: The incidence in the health service for the entire period was 1.48 % (5673/382 332). Diagnosed infection was highest among ambulance personnel and nursing home staff, with an incidence of 1.83 % (95/5203) and 1.86 % (1534/82 776), respectively. Doctors were tested most frequently (1.45 tests per person), and the proportion of positive tests was highest among cleaners (2.78 %) and ambulance personnel (1.57 %). Imported infection was highest for dentists (14.3 %), psychologists (12.8 %) and doctors (10.8 %).

Interpretation: There are variations in the incidence of diagnosed infections among employees in the health service. Some of this can likely be viewed in connection with high testing activity, imported infection, age and sex distribution, place of residence and country of birth, and outbreaks in different health services. More research and data are needed to ascertain whether occupational practice is associated with increased risk of SARS-CoV-2 infection.

Publication types

  • Comment

MeSH terms

  • Adult
  • Aged
  • Antibodies, Neutralizing
  • COVID-19*
  • Health Personnel
  • Humans
  • Middle Aged
  • Norway / epidemiology
  • Pandemics*
  • Prospective Studies
  • SARS-CoV-2
  • Young Adult

Substances

  • Antibodies, Neutralizing